GSK's RSV vaccine meets main goal when co-administered with shingles shot
British drugmaker GSK said on Wednesday its respiratory syncytial virus (RSV) vaccine, when given together with its shingles ...
GSK's RSV, Shingles vaccines show on-par immune response in joint trial
British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...
MarketWatch3d
GSK falls Wednesday, still outperforms market
Shares of GSK PLC GSK inched down 0.34% to £16.04 Wednesday, on what proved to be an all-around rough trading session for the ...
GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan
J.P. Morgan analyst James Gordon maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the ...
Axial Spondyloarthritis Market - US to Have the Lion's Share Among the 7MM | DelveInsight
Axial Spondyloarthritis (axSpA) is a form of arthritis that mainly causes discomfort and inflammation in the spine and ...
Nontuberculous Mycobacterial Infection Market to Exhibit Growth at a CAGR of 13.4% in the US by 2034 | DelveInsight
DelveInsight's Nontuberculous Mycobacterial Infection Market Insights report includes a comprehensive understanding of ...
Anervea.ai: Anervea Welcomes Jack Capponi as Chief Commercial Officer and Board Member, Driving Global Expansion with AI-Powered Solutions
Anervea.ai, a global leader in AI-powered commercialization solutions for the Pharmaceutical, Life Sciences, and Biotech industries, is pleased ...